{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T22:13:06Z","timestamp":1794694386095,"version":"4.9.1"},"reference-count":66,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,15]],"date-time":"2021-12-15T00:00:00Z","timestamp":1639526400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009619","name":"AMED","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002241","name":"JST","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002241","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.celrep.2021.110218","type":"journal-article","created":{"date-parts":[[2021,12,18]],"date-time":"2021-12-18T00:25:28Z","timestamp":1639787128000},"page":"110218","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":148,"title":["The SARS-CoV-2 Lambda variant exhibits enhanced infectivity and immune resistance"],"prefix":"10.1016","volume":"38","author":[{"given":"Izumi","family":"Kimura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Kosugi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaqi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8698-4236","authenticated-orcid":false,"given":"Jiri","family":"Zahradnik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daichi","family":"Yamasoba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika P.","family":"Butlertanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuri L.","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiya","family":"Uriu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5356-6599","authenticated-orcid":false,"given":"Yafei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nanami","family":"Morizako","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kotaro","family":"Shirakawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiro","family":"Kazuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryosuke","family":"Nomura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihito","family":"Horisawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenzo","family":"Tokunaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4852-4236","authenticated-orcid":false,"given":"Takamasa","family":"Ueno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7678-4284","authenticated-orcid":false,"given":"Akifumi","family":"Takaori-Kondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2922-5882","authenticated-orcid":false,"given":"Gideon","family":"Schreiber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1153-3166","authenticated-orcid":false,"given":"Hisashi","family":"Arase","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chihiro","family":"Motozono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2792-4399","authenticated-orcid":false,"given":"Akatsuki","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1760-3839","authenticated-orcid":false,"given":"So","family":"Nakagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4431-1380","authenticated-orcid":false,"given":"Kei","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.celrep.2021.110218_bib1","doi-asserted-by":"crossref","first-page":"9605","DOI":"10.1128\/JVI.78.18.9605-9611.2004","article-title":"Effect of the addition of oligosaccharides on the biological activities and antigenicity of influenza A\/H3N2 virus hemagglutinin","volume":"78","author":"Abe","year":"2004","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.celrep.2021.110218_bib2","first-page":"21259673","article-title":"Infectivity and immune escape of the new SARS-CoV-2 variant of interest Lambda","author":"Acevedo","year":"2021","journal-title":"MedRxiv"},{"key":"10.1016\/j.celrep.2021.110218_bib3","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/s41591-021-01294-w","article-title":"Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies","volume":"27","author":"Chen","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.celrep.2021.110218_bib4","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1126\/science.abc6952","article-title":"A neutralizing human antibody binds to the N-terminal domain of the Spike protein of SARS-CoV-2","volume":"369","author":"Chi","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.celrep.2021.110218_bib5","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/s41586-021-03412-7","article-title":"Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies","volume":"593","author":"Collier","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2021.110218_bib6","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1093\/infdis\/jiab368","article-title":"SARS-CoV-2 B.1.617 mutations L452R and E484Q are not synergistic for antibody evasion","volume":"224","author":"Ferreira","year":"2021","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.celrep.2021.110218_bib7","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1110\/ps.9.9.1753","article-title":"Modeling of loops in protein structures","volume":"9","author":"Fiser","year":"2000","journal-title":"Protein Sci."},{"key":"10.1016\/j.celrep.2021.110218_bib8","doi-asserted-by":"crossref","first-page":"102311","DOI":"10.1016\/j.isci.2021.102311","article-title":"Learning from HIV-1 to predict the immunogenicity of T\u00a0cell epitopes in SARS-COV-2","author":"Gao","year":"2021","journal-title":"iScience"},{"key":"10.1016\/j.celrep.2021.110218_bib9","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1016\/j.cell.2021.03.013","article-title":"Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity","volume":"184","author":"Garcia-Beltran","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2021.110218_bib10","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1126\/science.abi6226","article-title":"Effect of natural mutations of SARS-CoV-2 on spike structure, conformation, and antigenicity","volume":"373","author":"Gobeil","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.celrep.2021.110218_bib11","first-page":"D783","article-title":"Allele frequency net database (AFND) 2020 update: gold-standard data classification, open access genotype data and new query tools","volume":"48","author":"Gonzalez-Galarza","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.celrep.2021.110218_bib12","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1056\/NEJMoa2105000","article-title":"Vaccine breakthrough infections with SARS-CoV-2 variants","volume":"384","author":"Hacisuleyman","year":"2021","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.celrep.2021.110218_bib13","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/s41579-021-00573-0","article-title":"SARS-CoV-2 variants, spike mutations and immune escape","volume":"19","author":"Harvey","year":"2021","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.celrep.2021.110218_bib14","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.1016\/j.cell.2021.03.036","article-title":"SARS-CoV-2 variants B.1.351 and P.1 escape from neutralizing antibodies","volume":"184","author":"Hoffmann","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2021.110218_bib15","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.gendis.2021.05.006","article-title":"Identification of cross-reactive CD8+ T cell receptors with high functional avidity to a SARS-CoV-2 immunodominant epitope and its natural mutant variants","volume":"9","author":"Hu","year":"2021","journal-title":"Genes Dis."},{"key":"10.1016\/j.celrep.2021.110218_bib16","doi-asserted-by":"crossref","first-page":"5179","DOI":"10.1016\/j.cell.2021.08.014","article-title":"Generation and transmission of interlineage recombinants in the SARS-CoV-2 pandemic","volume":"184","author":"Jackson","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2021.110218_bib17","article-title":"Post-vaccination SARS-CoV-2 infections and incidence of presumptive B.1.427\/B.1.429 variant among healthcare personnel at a northern California academic medical center","author":"Jacobson","year":"2021","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.celrep.2021.110218_bib18","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1056\/NEJMoa2107715","article-title":"Effectiveness of an inactivated SARS-CoV-2 vaccine in Chile","volume":"385","author":"Jara","year":"2021","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.celrep.2021.110218_bib19","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/BF00216838","article-title":"HLA-B51 transgenic mice as recipients for production of polymorphic HLA-A, B-specific antibodies","volume":"37","author":"Karaki","year":"1993","journal-title":"Immunogenetics"},{"key":"10.1016\/j.celrep.2021.110218_bib20","doi-asserted-by":"crossref","DOI":"10.1172\/JCI145476","article-title":"SARS-CoV-2-specific CD8+ T\u00a0cell responses in convalescent COVID-19 individuals","volume":"131","author":"Kared","year":"2021","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.celrep.2021.110218_bib21","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1093\/molbev\/mst010","article-title":"MAFFT multiple sequence alignment software version 7: improvements in performance and usability","volume":"30","author":"Katoh","year":"2013","journal-title":"Mol. Biol. Evol."},{"key":"10.1016\/j.celrep.2021.110218_bib22","doi-asserted-by":"crossref","first-page":"3446","DOI":"10.1128\/JVI.06147-11","article-title":"Evidence for N-glycan shielding of antigenic sites during evolution of human influenza A virus hemagglutinin","volume":"86","author":"Kobayashi","year":"2012","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.celrep.2021.110218_bib23","doi-asserted-by":"crossref","first-page":"4203","DOI":"10.1016\/j.cell.2021.06.021","article-title":"In\u00a0vitro and in\u00a0vivo functions of SARS-CoV-2 infection-enhancing and neutralizing antibodies","volume":"184","author":"Li","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2021.110218_bib24","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/j.cell.2020.07.012","article-title":"The impact of mutations in SARS-CoV-2 spike on viral infectivity and antigenicity","volume":"182","author":"Li","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2021.110218_bib25","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1128\/JVI.01691-07","article-title":"Removal of a single N-linked glycan in human immunodeficiency virus type 1 gp120 results in an enhanced ability to induce neutralizing antibody responses","volume":"82","author":"Li","year":"2008","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.celrep.2021.110218_bib26","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/s41586-021-03693-y","article-title":"BNT162b2-elicited neutralization of B.1.617 and other SARS-CoV-2 variants","volume":"596","author":"Liu","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2021.110218_bib27","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1056\/NEJMc2102017","article-title":"Neutralizing activity of BNT162b2-elicited serum","volume":"384","author":"Liu","year":"2021","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.celrep.2021.110218_bib28","doi-asserted-by":"crossref","first-page":"3452","DOI":"10.1016\/j.cell.2021.05.032","article-title":"An infectivity-enhancing site on the SARS-CoV-2 spike protein targeted by antibodies","volume":"184","author":"Liu","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2021.110218_bib29","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.chom.2021.04.010","article-title":"An NTD supersite of attack","volume":"29","author":"Lok","year":"2021","journal-title":"Cell Host Microbe."},{"key":"10.1016\/j.celrep.2021.110218_bib30","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1016\/j.cell.2021.03.028","article-title":"N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2","volume":"184","author":"McCallum","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2021.110218_bib31","doi-asserted-by":"crossref","first-page":"109292","DOI":"10.1016\/j.celrep.2021.109292","article-title":"Recurrent emergence of SARS-CoV-2 spike deletion H69\/V70 and its role in the Alpha variant B.1.1.7","volume":"35","author":"Meng","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.celrep.2021.110218_bib32","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1093\/molbev\/msaa015","article-title":"IQ-TREE 2: new models and efficient methods for phylogenetic inference in the genomic era","volume":"37","author":"Minh","year":"2020","journal-title":"Mol. Biol. Evol."},{"key":"10.1016\/j.celrep.2021.110218_bib33","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/s41586-021-03944-y","article-title":"SARS-CoV-2 B.1.617.2 Delta variant replication and immune evasion","volume":"599","author":"Mlcochova","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2021.110218_bib34","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.chom.2021.06.006","article-title":"SARS-CoV-2 spike L452R variant evades cellular immunity and increases infectivity","volume":"29","author":"Motozono","year":"2021","journal-title":"Cell Host Microbe."},{"key":"10.1016\/j.celrep.2021.110218_bib35","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0378-1119(91)90434-D","article-title":"Efficient selection for high-expression transfectants with a novel eukaryotic vector","volume":"108","author":"Niwa","year":"1991","journal-title":"Gene"},{"key":"10.1016\/j.celrep.2021.110218_bib36","first-page":"e7","article-title":"Vaccine breakthrough infections with SARS-CoV-2 variants","volume":"385","author":"Nixon","year":"2021","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.celrep.2021.110218_bib37","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1038\/s41467-021-21118-2","article-title":"SARS-CoV-2 D614G spike mutation increases entry efficiency with enhanced ACE2-binding affinity","volume":"12","author":"Ozono","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celrep.2021.110218_bib38","doi-asserted-by":"crossref","first-page":"13023","DOI":"10.1074\/jbc.RA120.013887","article-title":"Super-rapid quantitation of the production of HIV-1 harboring a luminescent peptide tag","volume":"295","author":"Ozono","year":"2020","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.celrep.2021.110218_bib39","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/978-1-62703-764-8_6","article-title":"Application of the restriction-free (RF) cloning for multicomponents assembly","volume":"1116","author":"Peleg","year":"2014","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.celrep.2021.110218_bib40","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.cell.2020.09.037","article-title":"Mapping neutralizing and immunodominant sites on the SARS-CoV-2 spike receptor-binding domain by structure-guided high-resolution serology","volume":"183","author":"Piccoli","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2021.110218_bib41","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/s41591-021-01318-5","article-title":"Sensitivity of infectious SARS-CoV-2 B.1.1.7 and B.1.351 variants to neutralizing antibodies","volume":"27","author":"Planas","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.celrep.2021.110218_bib42","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/s41586-020-2895-3","article-title":"Spike mutation D614G alters SARS-CoV-2 fitness","volume":"592","author":"Plante","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2021.110218_bib43","doi-asserted-by":"crossref","first-page":"4199","DOI":"10.1128\/JVI.76.9.4199-4211.2002","article-title":"Role of N-linked glycans in a human immunodeficiency virus envelope glycoprotein: effects on protein function and the neutralizing antibody response","volume":"76","author":"Quinones-Kochs","year":"2002","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.celrep.2021.110218_bib44","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1038\/s41564-020-0770-5","article-title":"A dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiology","volume":"5","author":"Rambaut","year":"2020","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.celrep.2021.110218_bib45","first-page":"e7","article-title":"Vaccine breakthrough infections with SARS-CoV-2 variants","volume":"385","author":"Rana","year":"2021","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.celrep.2021.110218_bib46","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/nm0698-679","article-title":"A role for carbohydrates in immune evasion in AIDS","volume":"4","author":"Reitter","year":"1998","journal-title":"Nat. Med."},{"key":"10.1016\/j.celrep.2021.110218_bib47","article-title":"Enhanced fusogenicity and pathogenicity of SARS-CoV-2 Delta P681R mutation","author":"Saito","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2021.110218_bib48","doi-asserted-by":"crossref","first-page":"5000","DOI":"10.1128\/JVI.07062-11","article-title":"Vpu augments the initial burst phase of HIV-1 propagation and downregulates BST2 and CD4 in humanized mice","volume":"86","author":"Sato","year":"2012","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.celrep.2021.110218_bib49","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003812","article-title":"HIV-1 Vpr accelerates viral replication during acute infection by exploitation of proliferating CD4+ T\u00a0cells in\u00a0vivo","volume":"9","author":"Sato","year":"2013","journal-title":"PLOS Pathog."},{"key":"10.1016\/j.celrep.2021.110218_bib50","doi-asserted-by":"crossref","first-page":"5663","DOI":"10.1182\/blood-2010-09-305979","article-title":"A novel animal model of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in humanized mice","volume":"117","author":"Sato","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.celrep.2021.110218_bib51","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1073\/pnas.81.6.1779","article-title":"A carbohydrate side chain on hemagglutinins of Hong Kong influenza viruses inhibits recognition by a monoclonal antibody","volume":"81","author":"Skehel","year":"1984","journal-title":"Proc. Natl. Acad. Sci. U S A."},{"key":"10.1016\/j.celrep.2021.110218_bib52","doi-asserted-by":"crossref","first-page":"vey016","DOI":"10.1093\/ve\/vey016","article-title":"Bayesian phylogenetic and phylodynamic data integration using BEAST 1.10","volume":"4","author":"Suchard","year":"2018","journal-title":"Virus Evol."},{"key":"10.1016\/j.celrep.2021.110218_bib53","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00850-21","article-title":"Replicative fitness of a SARS-CoV-2 20I\/501Y.V1 variant from lineage B.1.1.7 in human reconstituted bronchial epithelium","volume":"12","author":"Touret","year":"2021","journal-title":"mBio"},{"key":"10.1016\/j.celrep.2021.110218_bib54","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/COH.0000000000000639","article-title":"Hitting the sweet spot: exploiting HIV-1 glycan shield for induction of broadly neutralizing antibodies","volume":"15","author":"Wagh","year":"2020","journal-title":"Curr. Opin. HIV AIDS"},{"key":"10.1016\/j.celrep.2021.110218_bib55","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0140-6736(21)01462-8","article-title":"AZD1222-induced neutralising antibody activity against SARS-CoV-2 Delta VOC","volume":"398","author":"Wall","year":"2021","journal-title":"Lancet."},{"key":"10.1016\/j.celrep.2021.110218_bib56","doi-asserted-by":"crossref","first-page":"18137","DOI":"10.1073\/pnas.0909696106","article-title":"Glycans on influenza hemagglutinin affect receptor binding and immune response","volume":"106","author":"Wang","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U S A."},{"key":"10.1016\/j.celrep.2021.110218_bib57","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.chom.2021.04.007","article-title":"Increased resistance of SARS-CoV-2 variant P.1 to antibody neutralization","volume":"29","author":"Wang","year":"2021","journal-title":"Cell Host Microbe."},{"key":"10.1016\/j.celrep.2021.110218_bib58","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/s41586-021-03398-2","article-title":"Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7","volume":"593","author":"Wang","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2021.110218_bib59","author":"WHO"},{"key":"10.1016\/j.celrep.2021.110218_bib60","author":"WHO"},{"key":"10.1016\/j.celrep.2021.110218_bib61","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1182\/blood-2006-11-056168","article-title":"Activation-induced expression of CD137 permits detection, isolation, and expansion of the full repertoire of CD8+ T\u00a0cells responding to antigen without requiring knowledge of epitope specificities","volume":"110","author":"Wolfl","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.celrep.2021.110218_bib62","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1038\/s41594-020-0468-7","article-title":"SARS-CoV-2 and bat RaTG13 spike glycoprotein structures inform on virus evolution and furin-cleavage effects","volume":"27","author":"Wrobel","year":"2020","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.celrep.2021.110218_bib63","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1126\/science.abb2762","article-title":"Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2","volume":"367","author":"Yan","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.celrep.2021.110218_bib64","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.cell.2020.09.032","article-title":"Structural and functional analysis of the D614G SARS-CoV-2 spike protein variant","volume":"183","author":"Yurkovetskiy","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2021.110218_bib65","doi-asserted-by":"crossref","first-page":"3445","DOI":"10.1021\/acssynbio.1c00395","article-title":"A protein-engineered, enhanced yeast display platform for rapid evolution of challenging targets","volume":"10","author":"Zahradn\u00edk","year":"2021","journal-title":"Acs. Synth. Biol."},{"key":"10.1016\/j.celrep.2021.110218_bib66","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1038\/s41564-021-00954-4","article-title":"SARS-CoV-2 variant prediction and antiviral drug design are enabled by RBD in\u00a0vitro evolution","volume":"6","author":"Zahradnik","year":"2021","journal-title":"Nat. Microbiol."}],"container-title":["Cell Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211124721017228?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211124721017228?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T11:32:33Z","timestamp":1761910353000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211124721017228"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":66,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["S2211124721017228"],"URL":"https:\/\/doi.org\/10.1016\/j.celrep.2021.110218","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2021.07.28.454085","asserted-by":"object"}]},"ISSN":["2211-1247"],"issn-type":[{"value":"2211-1247","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The SARS-CoV-2 Lambda variant exhibits enhanced infectivity and immune resistance","name":"articletitle","label":"Article Title"},{"value":"Cell Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.celrep.2021.110218","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s).","name":"copyright","label":"Copyright"}],"article-number":"110218"}}